Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma in the East Asian Subgroup of the Phase 3 KEYNOTE-564 Study
KEYNOTE-564 III期研究东亚亚组中肾细胞癌辅助治疗帕博利珠单抗与安慰剂的比较
期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2025.365
Park, Se Hoon; Chang, Yen-Hwa; Lee, Jae Lyun; Choueiri, Toni K; Kimura, Go; Chung, Jinsoo; Masumori, Naoya; Nishimura, Kazuo; Kato, Minoru; Kato, Haruaki; Numakura, Kazuyuki; Chang, Chao-Hsiang; Anai, Satoshi; Tsunemori, Hiroyuki; Chen, Chung-Hsin; Lin, Jianxin; Elfiky, Aymen; Burgents, Joseph E; Kitamura, Hiroshi